Tipifarnib in Subjects With Chronic Myelomonocytic Leukemia, Other MDS/MPN, and Acute Myeloid Leukemia
Clinical trial NCT02807272 · COMPLETED
Trial details
- NCT number
- NCT02807272
- Sponsor
- Kura Oncology, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-10
- Primary completion
- 2020-11-30
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.